Abtrace

Abtrace, founded in 2018, is leveraging Machine Learning and cutting-edge clinical innovation to transform the landscape of primary care. Based in the United Kingdom, Abtrace is positioned at the intersection of AI, Healthcare, Medical Devices, and Machine Learning.

The company's emphasis on integrating AI and NLP technologies into healthcare solutions underscores its mission of reshaping the delivery of primary care, ensuring it is more efficient and accessible. Abtrace's focus on innovation makes it particularly relevant and timely, as the global demand for enhanced healthcare technologies continues to grow.

The most recent investment, a Non Equity Assistance secured on 03 July 2023, was backed by DigitalHealth.London. This strategic support reflects confidence in Abtrace’s vision and its potential to disrupt and advance the healthcare industry. Investors should note Abtrace’s promising position within a market ripe for technological intervention and scalability.